Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
3.810
-0.180 (-4.51%)
Nov 16, 2026, 4:00 PM EST - Market closed
Vanda Pharmaceuticals Revenue
Vanda Pharmaceuticals had revenue of $69.82M in the quarter ending September 30, 2026, with 24.10% growth. This brings the company's total for the last twelve months to $229.28M, up 8.11% year-over-year. In the year 2025, Vanda Pharmaceuticals had annual revenue of $216.11M with 8.72% growth. That makes Vanda Pharmaceuticals the 16,511th largest company in the world by revenue and 2,792nd in the United States.
Revenue (ttm)
$229.28M
Revenue Growth
+8.11%
P/S Ratio
1.00
Revenue / Employee
$430,165
Employees
533
Market Cap
230.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 216.11M | 17.33M | 8.72% |
| Dec 31, 2024 | 198.77M | 6.13M | 3.18% |
| Dec 31, 2023 | 192.64M | -61.74M | -24.27% |
| Dec 31, 2022 | 254.38M | -14.30M | -5.32% |
| Dec 31, 2021 | 268.68M | 20.51M | 8.27% |
| Dec 31, 2020 | 248.17M | 20.98M | 9.23% |
| Dec 31, 2019 | 227.19M | 34.07M | 17.64% |
| Dec 31, 2018 | 193.12M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 146.02M | 36.09M | 32.83% |
| Dec 31, 2015 | 109.93M | 59.77M | 119.16% |
| Dec 31, 2014 | 50.16M | 16.28M | 48.05% |
| Dec 31, 2013 | 33.88M | 1.15M | 3.52% |
| Dec 31, 2012 | 32.73M | 1.46M | 4.66% |
| Dec 31, 2011 | 31.27M | -4.44M | -12.43% |
| Dec 31, 2010 | 35.71M | 31.16M | 685.16% |
| Dec 31, 2009 | 4.55M | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bicycle Therapeutics | 83.53M |
| Clinuvel Pharmaceuticals | 65.05M |
| vTv Therapeutics | 36.84M |
| Arcturus Therapeutics Holdings | 30.51M |
| Lineage Cell Therapeutics | 10.84M |
| Camp4 Therapeutics | 5.32M |
VNDA News
- 5 days ago - NEREUS™ - The Goat of Biscayne Bay Arrives for Miami Art Week - PRNewsWire
- 5 days ago - Vanda Pharmaceuticals Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 13 days ago - Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences - PRNewsWire
- 19 days ago - Vanda Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 19 days ago - Vanda Pharmaceuticals Earnings release: Q3 2026 - Filings
- 19 days ago - Vanda Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 19 days ago - Vanda Pharmaceuticals reports Q3 EPS (37c) vs. (38c) last year - TheFly
- 19 days ago - Vanda Pharmaceuticals now sees FY26 revenue $240M, consensus $248.88M - TheFly